IBRX ImmunityBio, Inc.
Healthcare$7.22-6.72%ClosedMarket Cap: $7.56B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$13.00
Target (Median)
$12.00
Target Range
$12.00 - $15.00
Upside from current price: 80.1%
Rating Distribution
1 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-21 | BTIG | maintain | Buy | Buy |
| 2026-05-20 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-05 | D. Boral Capital | maintain | Buy | Buy |
| 2026-03-26 | D. Boral Capital | maintain | Buy | Buy |
| 2026-03-04 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-02-23 | D. Boral Capital | maintain | Buy | Buy |
| 2026-02-23 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-23 | D. Boral Capital | maintain | Buy | Buy |
| 2026-01-23 | BTIG | maintain | Buy | Buy |
| 2026-01-20 | Piper Sandler | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.05 | $518.3M | 2 |
| Sun Dec 31 | $0.48 | $1.20B | 2 |
| Mon Dec 31 | $1.09 | $2.22B | 1 |
| Tue Dec 31 | $1.94 | $3.74B | 1 |